ORRA GROUP

Ligand: developed innovative registration strategy for product for bone marrow transplants, designed pivotal trial that enrolled in record time, clinical lead of team that sold rights for over $50 million to Spectrum Pharmaceuticals... Performed functions of CMO for over 40 companies, resulting in raising over $1B; companies focus included oncology, hematology, immunology, vaccines, diagnostics; started & monitored multi-site/multi-country Phase 1-3 trials, developed global clinical strategy, set up advisory boards, wrote & submitted INDs & NDAs to FDA/EMEA... Directed team that started five major Phase I and Phase II trials for three products in oncology and hepatitis in two countries; medical monitor for first studies that evaluated role of ribozymes in disease